Sunday 27 November 2011

Didanosine Delayed-Release Enteric-Coated Capsules


Pronunciation: dye-DAN-oh-seen
Generic Name: Didanosine
Brand Name: Videx EC

Didanosine Delayed-Release Enteric-Coated Capsules may cause serious and sometimes fatal inflammation of the pancreas (pancreatitis). This has occurred in patients who have just started taking Didanosine Delayed-Release Enteric-Coated Capsules and in patients who have already been taking it. Contact your doctor right away if you experience sudden stomach or back pain, swelling of the stomach, fever or chills, nausea or vomiting, or fast heartbeat.


Didanosine Delayed-Release Enteric-Coated Capsules may cause severe and sometimes fatal lactic acidosis and liver problems. Fatal lactic acidosis has also occurred in pregnant women who have used Didanosine Delayed-Release Enteric-Coated Capsules along with certain other medicines for HIV (eg, stavudine). Tell your doctor if you are taking stavudine and you are pregnant or planning to become pregnant.





Didanosine Delayed-Release Enteric-Coated Capsules are used for:

Treating HIV infection when used in combination with other medicines.


Didanosine Delayed-Release Enteric-Coated Capsules are a nucleoside analogue reverse transcriptase inhibitor. It works by stopping the growth of HIV-1, the virus that causes AIDS.


Do NOT use Didanosine Delayed-Release Enteric-Coated Capsules if:


  • you are allergic to any ingredient in Didanosine Delayed-Release Enteric-Coated Capsules

  • you have pancreas inflammation (pancreatitis), certain liver problems (eg, enlarged liver, portal hypertension), abnormal liver function tests, or lactic acidosis

  • you are taking allopurinol or ribavirin

Contact your doctor or health care provider right away if any of these apply to you.



Before using Didanosine Delayed-Release Enteric-Coated Capsules:


Some medical conditions may interact with Didanosine Delayed-Release Enteric-Coated Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of heart problems (eg, heart attack)

  • if you have advanced HIV infection (AIDS), kidney problems, liver problems (eg, hepatitis), gallstones, nerve problems (neuropathy), high blood cholesterol or lipid levels, or high blood amylase levels

  • if you are overweight or you have a history of alcohol abuse

Some MEDICINES MAY INTERACT with Didanosine Delayed-Release Enteric-Coated Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Hydroxyurea because the risk of pancreatitis may be increased

  • Allopurinol, ganciclovir, nucleotide reverse transcriptase inhibitors (eg, tenofovir), or ribavirin because they may increase the risk of Didanosine Delayed-Release Enteric-Coated Capsules's side effects

  • Methadone because it may decrease Didanosine Delayed-Release Enteric-Coated Capsules's effectiveness

  • Aluminum salts (eg, aluminum hydroxide) because the risk of their side effects may be increased by Didanosine Delayed-Release Enteric-Coated Capsules

  • Azole antifungals (eg, itraconazole, ketoconazole), delavirdine, HIV protease inhibitors (eg, indinavir, lopinavir, nelfinavir), lithium, quinolones (eg, ciprofloxacin, levofloxacin), sulfones (eg, dapsone), or tetracyclines (eg, doxycycline) because their effectiveness may be decreased by Didanosine Delayed-Release Enteric-Coated Capsules

  • Stavudine because the risk of pancreatitis or fatal lactic acidosis in pregnant women may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Didanosine Delayed-Release Enteric-Coated Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Didanosine Delayed-Release Enteric-Coated Capsules:


Use Didanosine Delayed-Release Enteric-Coated Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Didanosine Delayed-Release Enteric-Coated Capsules comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Didanosine Delayed-Release Enteric-Coated Capsules refilled.

  • Take Didanosine Delayed-Release Enteric-Coated Capsules by mouth on an empty stomach at least 1 hour before or 2 hours after eating.

  • Swallow Didanosine Delayed-Release Enteric-Coated Capsules whole. Do not break, crush, or chew before swallowing.

  • Didanosine Delayed-Release Enteric-Coated Capsules may reduce the effectiveness of certain other medicines when taken together. Ask your doctor or pharmacist if you should separate Didanosine Delayed-Release Enteric-Coated Capsules from any other medicine that you are taking.

  • Continue to take Didanosine Delayed-Release Enteric-Coated Capsules even if you feel well. Do not miss any doses.

  • If you miss a dose of Didanosine Delayed-Release Enteric-Coated Capsules, take it as soon as you remember. If it is within 2 hours of your next dose, skip the missed dose and go back to your regular dosing schedule. It is important not to miss doses of Didanosine Delayed-Release Enteric-Coated Capsules. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Didanosine Delayed-Release Enteric-Coated Capsules.



Important safety information:


  • Do not drink alcohol while you are taking Didanosine Delayed-Release Enteric-Coated Capsules.

  • Didanosine Delayed-Release Enteric-Coated Capsules are not a cure for HIV infection. Patients may still get illnesses and infections associated with HIV. Remain under the care of your doctor.

  • Didanosine Delayed-Release Enteric-Coated Capsules does not stop the spread of HIV to others through blood or sexual contact. Use barrier methods of birth control (eg, condoms) if you have HIV infection. Do not share needles, injection supplies, or items like toothbrushes or razors.

  • When your medicine supply is low, get more from your doctor or pharmacist as soon as you can. Do not stop taking Didanosine Delayed-Release Enteric-Coated Capsules, even for a short period of time. If you do, the virus may grow resistant to the medicine and become harder to treat.

  • Tell your doctor or dentist that you take Didanosine Delayed-Release Enteric-Coated Capsules before you receive any medical or dental care, emergency care, or surgery.

  • The risk of severe side effects (eg, lactic acidosis, severe liver problems) may be greater in women, patients who are overweight (obese), and patients who have taken reverse transcriptase inhibitors (eg, emtricitabine, tenofovir) for a long time. Talk with your doctor if you have questions about your risk of severe side effects from Didanosine Delayed-Release Enteric-Coated Capsules.

  • Changes in body fat (eg, an increased amount of fat in the upper back, neck, breast, and trunk, and loss of fat from the legs, arms, and face) may occur in some patients taking Didanosine Delayed-Release Enteric-Coated Capsules. The cause and long-term effects of these changes are unknown. Discuss any concerns with your doctor.

  • Didanosine Delayed-Release Enteric-Coated Capsules may improve immune system function. This may reveal hidden infections in some patients. Tell your doctor right away if you notice symptoms of infection (eg, fever, sore throat, weakness, cough, shortness of breath) after you start Didanosine Delayed-Release Enteric-Coated Capsules.

  • Lab tests, including eye exams, liver function, complete blood cell counts, and blood clotting (eg, international normalized ratio [INR]), may be performed while you use Didanosine Delayed-Release Enteric-Coated Capsules. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Didanosine Delayed-Release Enteric-Coated Capsules with caution in the ELDERLY; they may be more sensitive to its effects.

  • Use Didanosine Delayed-Release Enteric-Coated Capsules with extreme caution in CHILDREN weighing less than 44 lb; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Didanosine Delayed-Release Enteric-Coated Capsules while you are pregnant. It is not known if Didanosine Delayed-Release Enteric-Coated Capsules are found in breast milk. Mothers infected with HIV should not breast-feed. There is a risk of passing the HIV infection or Didanosine Delayed-Release Enteric-Coated Capsules to the baby.


Possible side effects of Didanosine Delayed-Release Enteric-Coated Capsules:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Breast enlargement; changes in body fat; darkened complexion with purple markings; diarrhea; dry mouth; headache; itching; muscle pain; skin and facial wasting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; blood in the vomit or vomit that looks like coffee grounds; blurred vision or other vision changes; chest pain or discomfort, numbness of an arm or leg, or shortness of breath; confusion; dark urine; dizziness; fainting; fast, shallow breathing; fast, slow, or irregular heartbeat; fever, chills, or persistent sore throat; lightheadedness; low body temperature; nausea or vomiting; numbness, tingling, or pain in the hands or feet; pale stools; seizures; severe muscle pain or cramping; stomach pain or swelling; tiredness; unusual bruising or bleeding; weakness; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Didanosine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include dark urine; diarrhea; pale stools; severe stomach pain with nausea and vomiting; tingling, burning, or numbness in the hands or feet; unusual fatigue; yellowing of the skin or eyes.


Proper storage of Didanosine Delayed-Release Enteric-Coated Capsules:

Store Didanosine Delayed-Release Enteric-Coated Capsules at room temperature, between 59 and 77 degrees F (15 and 25 degrees C), in a tightly closed container. Brief storage at temperatures of up to 86 degrees F (30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Didanosine Delayed-Release Enteric-Coated Capsules out of the reach of children and away from pets.


General information:


  • If you have any questions about Didanosine Delayed-Release Enteric-Coated Capsules, please talk with your doctor, pharmacist, or other health care provider.

  • Didanosine Delayed-Release Enteric-Coated Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Didanosine Delayed-Release Enteric-Coated Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Didanosine resources


  • Didanosine Side Effects (in more detail)
  • Didanosine Use in Pregnancy & Breastfeeding
  • Drug Images
  • Didanosine Drug Interactions
  • Didanosine Support Group
  • 0 Reviews for Didanosine - Add your own review/rating


Compare Didanosine with other medications


  • HIV Infection
  • Nonoccupational Exposure

Wednesday 23 November 2011

Losartan Cinfa




Losartan Cinfa may be available in the countries listed below.


Ingredient matches for Losartan Cinfa



Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Cinfa in the following countries:


  • Spain

International Drug Name Search

Tuesday 22 November 2011

Glutaral




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000111-30-8

Chemical Formula

C5-H8-O2

Molecular Weight

100

Therapeutic Categories

Antiseptic

Disinfectant

Antiviral agent

Chemical Name

Pentanedial

Foreign Names

  • Glutaralum (Latin)
  • Glutaral (German)
  • Glutaral (French)
  • Glutaral (Spanish)

Generic Names

  • Glutaral (OS: JAN, USAN)
  • Glutaral Concentrate (PH: USP 32)
  • Glutaraldehyde Solution, Strong (PH: BP 2010)

Brand Names

  • Cidex
    Johnson & Johnson, Japan


  • Cleanhyde
    Nichi-Iko PharmaceuticalJMA, Japan


  • Diswart
    Dermatech, Australia


  • Ecosafe (veterinary use)
    Ecolab, New Zealand


  • Eso (veterinary use)
    Esoform Vet, Italy


  • Glutarol
    Dermal, United Kingdom; Dermal, Ireland


  • Glutohyde
    Yoshida Seiyaku, Japan


  • Glutohyde L
    Yoshida Seiyaku, Japan


  • Glutohyde Plus
    Yoshida Seiyaku, Japan


  • Glutohyde Scope
    Yoshida Seiyaku, Japan


  • Gutarhyde
    Saraya, Japan


  • Hycidal
    Panion & BF, Taiwan


  • Hydolit
    Nikko Seiyaku, Japan


  • Korsolex
    Bode, Germany


  • Leo Yellow Super Dip (veterinary use)
    Leo, United Kingdom


  • Sekusept Extra (Glutaral and Benzalkonium Chloride)
    Ecolab, Germany


  • Solescope
    Nipro PharmaNipurofama, Japan


  • Solesol
    L Nipro PharmaNipurofama, Japan


  • Sterihyde
    Maruishi, Japan


  • Steriscope
    Maruishi, Japan


  • Sterisol
    Toyo Seiyaku KaseiOriental, Japan


  • Terminator (Glutaral and Benzalkonium (veterinary use))
    Bomac, New Zealand


  • Washlite
    Pola Pharma, Japan

International Drug Name Search

Glossary

JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday 12 November 2011

Vispazine




Vispazine may be available in the countries listed below.


Ingredient matches for Vispazine



Tiemonium Methylsulfate

Tiemonium Methylsulfate is reported as an ingredient of Vispazine in the following countries:


  • Bangladesh

International Drug Name Search

Uni Dose




Uni Dose may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Uni Dose



Metrifonate

Metrifonate is reported as an ingredient of Uni Dose in the following countries:


  • South Africa

International Drug Name Search

Monday 7 November 2011

RIF




RIF may be available in the countries listed below.


Ingredient matches for RIF



Rifampicin

Rifampicin is reported as an ingredient of RIF in the following countries:


  • Indonesia

Rifamycin

Rifamycin is reported as an ingredient of RIF in the following countries:


  • Bosnia & Herzegowina

  • Turkey

International Drug Name Search

Friday 4 November 2011

Ritemed Gliclazide




Ritemed Gliclazide may be available in the countries listed below.


Ingredient matches for Ritemed Gliclazide



Gliclazide

Gliclazide is reported as an ingredient of Ritemed Gliclazide in the following countries:


  • Philippines

International Drug Name Search